64
Participants
Start Date
May 31, 2005
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
Triamcinolone acetate
When indicated, intravitreal triamcinolone (0.1 ml of Kenacort 40© \[40mg/ml triamcinolone acetonide, Bristol-Myers Squibb pharmaceuticals, Australia\]) was injected into the vitreous under sterile conditions in a minor procedures area.
Save Sight Institute, Sydney/Sydney Eye Hospital Campus, University of Sydney, Sydney
University of Sydney
OTHER